John Dobak - 08 Dec 2021 Form 4 Insider Report for DermTech, Inc.

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: N/A
Reported as of: 08 Dec 2021
Net transaction value: -$20,657
SEC form: 4
Accepted by SEC: 10 Dec 2021, 19:03:53 UTC
Prior SEC filing: 15 Sep 2021
Next SEC filing: 16 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Jason S. Miller, attorney-in-fact

Key filing fact

John Dobak filed Form 4 for DermTech, Inc. on 10 Dec 2021.

Key facts

This page summarizes John Dobak's Form 4 filing for DermTech, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Dec 2021, 19:03.

Change

Previous filing in this sequence was filed on 15 Sep 2021.
Current net transaction value: -$20,657.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DMTK transaction

Common Stock

Sale

Transaction value: $20,657
Shares: -1,119
Change %: -0.25%
Price: $18.46^*
Shares after: 452,526
Date: 08 Dec 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.